1 active not recruiting, 1 recruiting. 2 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Active not recruiting 1, Recruiting 1 |
| Phase 3 | 1 | Active not recruiting 1 |
Follow Crofelemer Powder for Oral Solution: new trials by email Literature Review of Crofelemer Powder for Oral Solution trials Research Report on Crofelemer Powder for Oral Solution
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Efficacy of Crofelemer in Adult Patients With Short Bowel Syndrome and Intestinal Failure (SBS-IF) Without Colon-in-continuity (CIC) Crofelemer Powder for Oral Solution, Matched Placebo Powder for Oral Solution - Short Bowel Syndrome, Malabsorption Syndromes | Phase 2 | Recruiting | Napo Therapeutics, S.p.A. | 18 | 2025-05-29 | 2026-06-09 |
| Ascending Doses of Crofelemer Powder for Oral Solution in Pediatric Microvillus Inclusion Disease (MVID) Crofelemer Powder for Oral Solution, Placebo Powder for Oral Solution - Microvillus Inclusion Disease, Congenital Disorders | Phase 2 / Phase 3 | Active not recruiting | Napo Pharmaceuticals, Inc. | 6 | 2025-05-01 | 2026-06-09 |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Gastrointestinal Diseases (1) · Malabsorption Syndromes (1) · Microvillus inclusion disease (1) · Postoperative Complications (1) · Rare Diseases (1) · Short Bowel Syndrome (1)
Napo Pharmaceuticals, Inc. (1) · Napo Therapeutics, S.p.A. (1)
Italy (2) · Germany (1) · United Arab Emirates (1) · United States (1)